Literature DB >> 33499347

Impact of a Gender-Neutral HPV Vaccination Program in Men Who Have Sex with Men (MSM).

Javier Díez-Domingo1, Víctor Sánchez-Alonso2, Rafael-J Villanueva2, Luis Acedo3, José Tuells4.   

Abstract

A major challenge in human papillomavirus (HPV) vaccine programs is the universal gender-neutral recommendation, as well as estimation of its long-term effect. The objective of this study is to predict the added benefit of male vaccination, especially in men who have sex with men (MSM), and to analyze the impact of the program on society. We propose a mathematical model of the HPV infection based on a network paradigm. Data from Spain allowed constructing the sexual network. HPV force of infection was taken from literature. Different scenarios using variable vaccine coverage in both males and females were studied. Strong herd immunity is shown in the heterosexual population, with an important decrease of HPV 6/11 infections both in men and in unvaccinated women with an only-women vaccination at 14 years of age. No impact of this program occurred in the infection incidence in MSM. This group would only benefit from a vaccination program that includes males. However, the impact at short term would be lower than in heterosexual men. The protection of MSM can only be achieved by direct vaccination of males. This may have important consequences for public health.

Entities:  

Keywords:  epidemiologic transition; human papillomavirus; men who have sex with men; network model; sexual behavior; sexual partners; vaccination strategies

Year:  2021        PMID: 33499347      PMCID: PMC7908442          DOI: 10.3390/ijerph18030963

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  38 in total

1.  Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis.

Authors:  Lesley S Park; Raúl U Hernández-Ramírez; Michael J Silverberg; Kristina Crothers; Robert Dubrow
Journal:  AIDS       Date:  2016-01       Impact factor: 4.177

Review 2.  Epidemiology and burden of HPV-related disease.

Authors:  Beatriz Serrano; María Brotons; Francesc Xavier Bosch; Laia Bruni
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2017-09-02       Impact factor: 5.237

3.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States.

Authors:  Anil K Chaturvedi; Eric A Engels; Ruth M Pfeiffer; Brenda Y Hernandez; Weihong Xiao; Esther Kim; Bo Jiang; Marc T Goodman; Maria Sibug-Saber; Wendy Cozen; Lihua Liu; Charles F Lynch; Nicolas Wentzensen; Richard C Jordan; Sean Altekruse; William F Anderson; Philip S Rosenberg; Maura L Gillison
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

Review 4.  Is there an increased risk of cancer among spouses of patients with an HPV-related cancer: A systematic review.

Authors:  Haitham Mirghani; Erich M Sturgis; Anne Aupérin; Joseph Monsonego; Pierre Blanchard
Journal:  Oral Oncol       Date:  2017-02-28       Impact factor: 5.337

5.  Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study.

Authors:  Xavier Castellsagué; Thomas Iftner; Esther Roura; José Antonio Vidart; Susanne K Kjaer; F Xavier Bosch; Nubia Muñoz; Santiago Palacios; Maria San Martin Rodriguez; Laurence Serradell; Laurence Torcel-Pagnon; Javier Cortes
Journal:  J Med Virol       Date:  2012-06       Impact factor: 2.327

6.  Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm.

Authors:  Michelle M Rietbergen; C René Leemans; Elisabeth Bloemena; Daniëlle A M Heideman; Boudewijn J M Braakhuis; Albertus T Hesselink; Birgit I Witte; Robert J Baatenburg de Jong; Chris J L M Meijer; Peter J F Snijders; Ruud H Brakenhoff
Journal:  Int J Cancer       Date:  2012-11-23       Impact factor: 7.396

7.  Random Network Models to Predict the Long-Term Impact of HPV Vaccination on Genital Warts.

Authors:  Javier Díez-Domingo; Víctor Sánchez-Alonso; Rafael-J Villanueva; Luis Acedo; José-Antonio Moraño; Javier Villanueva-Oller
Journal:  Viruses       Date:  2017-10-16       Impact factor: 5.048

8.  Epidemiology of genital warts in the British population: implications for HPV vaccination programmes.

Authors:  Pam Sonnenberg; Clare Tanton; David Mesher; Eleanor King; Simon Beddows; Nigel Field; Catherine H Mercer; Kate Soldan; Anne M Johnson
Journal:  Sex Transm Infect       Date:  2019-02-05       Impact factor: 3.519

9.  Estimating the epidemiological impact and cost-effectiveness profile of a nonavalent HPV vaccine in Spain.

Authors:  Jesús De La Fuente; Juan José Hernandez Aguado; María San Martín; Paula Ramirez Boix; Sergio Cedillo Gómez; Noelia López
Journal:  Hum Vaccin Immunother       Date:  2019-02-20       Impact factor: 3.452

10.  Potential effectiveness of prophylactic HPV immunization for men who have sex with men in the Netherlands: A multi-model approach.

Authors:  Johannes A Bogaards; Sofie H Mooij; Maria Xiridou; Maarten F Schim van der Loeff
Journal:  PLoS Med       Date:  2019-03-04       Impact factor: 11.069

View more
  2 in total

Review 1.  Update on the Epidemiological Features and Clinical Implications of Human Papillomavirus Infection (HPV) and Human Immunodeficiency Virus (HIV) Coinfection.

Authors:  Alexandre Pérez-González; Edward Cachay; Antonio Ocampo; Eva Poveda
Journal:  Microorganisms       Date:  2022-05-18

2.  Factors influencing HPV vaccination willingness among men who have sex with men in China: a structural equation modeling analysis.

Authors:  Haiying Pan; Wei He; Bing Lin; Xiaoni Zhong
Journal:  Hum Vaccin Immunother       Date:  2022-03-11       Impact factor: 4.526

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.